Home > Financial Ratios > SAMRAT PHARMACHEM

SAMRAT PHARMACHEM
EV/Core EBITDA

    Back to All Ratios
COMMUNITY POLL
for SAMRAT PHARMACHEM
Please provide your vote to see the results

SAMRAT PHARMACHEM Last 5 Year EV/Core EBITDA History

[Standalone]

Mar2024Mar2023Mar2022Mar2021Mar2020
   EV/Core EBITDA(x) 26.404.985.735.293.71

What is the latest EV/Core EBITDA ratio of SAMRAT PHARMACHEM ?

The latest EV/Core EBITDA ratio of SAMRAT PHARMACHEM is 26.40 based on Mar2024 Standalone results.
Year EV/Core EBITDA
Mar202426.40
Mar20234.98
Mar20225.73
Mar20215.29
Mar20203.71

How is EV/Core EBITDA of SAMRAT PHARMACHEM Trending?

Years EV/Core EBITDA % Change
Mar2024 26.4
430.12
Mar2023 4.98
-13.09
Mar2022 5.73
8.32
Mar2021 5.29
42.59
Mar2020 3.71 -

Other Financial Ratios of SAMRAT PHARMACHEM


Compare EV/Core EBITDA ratio of peers of SAMRAT PHARMACHEM

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
SAMRAT PHARMACHEM ₹98.8 Cr -2.5% -1.4% -48.9% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹391,368.0 Cr 0.7% -0.7% -11% Stock Analytics
DIVIS LABORATORIES ₹160,631.0 Cr NA -1.6% 12.1% Stock Analytics
TORRENT PHARMACEUTICALS ₹123,641.0 Cr 3.1% -0.9% 9.1% Stock Analytics
CIPLA ₹123,419.0 Cr -2% -4% -5.9% Stock Analytics
DR REDDYS LABORATORIES ₹109,176.0 Cr -0.2% 2.4% 0% Stock Analytics


SAMRAT PHARMACHEM Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
SAMRAT PHARMACHEM

-2.5%

-1.4%

-48.9%

SENSEX

-0.3%

0.1%

-1%


You may also like the below Video Courses